Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

TCR2 Therapeutics Inc. (TCRR)

13.96   -0.72 (-4.9%) 02-21 16:00
Open: 14.7 Pre. Close: 14.68
High: 14.7 Low: 13.77
Volume: 39,425 Market Cap: 336M
TCR2 Therapeutics Inc., a clinical-stage immunotherapy company, develops novel T cell receptor therapies for patients suffering from cancer. The company's lead product candidates include TC-210, mono TCR Fusion Construct T cells (TRuC-T cells) targeting mesothelin positive solid tumors, which initiated in phase I/II clinical trial for the treatment of non-small cell lung cancer (NSCLC), ovarian cancer, malignant pleural/peritoneal mesothelioma, and cholangiocarcinoma; and TC-110 a TRuC-T cell targeting CD19-positive B-Cell hematological malignancies. Its product candidates in pipeline comprise TC-220, a TRuC-T cell that targets MUC16 positive solid tumors; TC-310, a dual TRuC-T cells targeting both CD19 and CD22; and TC-410, a dual TRuC-T cell targeting both mesothelin and MUC16. The company has a cooperative research and development agreement with the National Cancer Institute to collaborate on the use of TCR2 proprietary T cell receptor Fusion Construct T cells as a cancer

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 14.715 - 14.795 14.795 - 14.862
Low: 13.582 - 13.679 13.679 - 13.759
Close: 13.813 - 13.962 13.962 - 14.085

Technical analysis

as of: 2020-02-21 4:34:19 PM
Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected.
Target: Six months: 17.63     One year: 19.35
Support: Support1: 12.70    Support2: 10.57
Resistance: Resistance1: 15.09    Resistance2: 16.57
Pivot: 14.61
Moving Average: MA(5): 14.33     MA(20): 14.78
MA(100): 15.17     MA(250): 15.78
MACD: MACD(12,26): -0.24     Signal(9): -0.22
Stochastic oscillator: %K(14,3): 51.49     %D(3): 49.50
RSI: RSI(14): 44.35
52-week: High: 25.47  Low: 10.04  Change(%): -14.8
Average Vol(K): 3-Month: 9482  10-Days: 6238

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
TCRR has closed above bottom band by 26.3%. Bollinger Bands are 18.6% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Thu, 03 Oct 2019 17:25:08 +0000
Thursday Sector Leaders: Application Software, Biotechnology Stocks

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NasdaqGS
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 24.03
Shares Float (M) 11.76
% Held by Insiders 19.58
% Held by Institutions 68.33
Shares Short (K) 961
Shares Short P. Month (K)

Stock Financials

EPS -6.290
Book Value (p.s.) 7.150
PEG Ratio
Profit Margin
Operating Margin
Return on Assets (ttm) -18.4
Return on Equity (ttm) -28.2
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.) -1.897
Qtrly Earnings Growth
Operating Cash Flow (M) -37.52
Levered Free Cash Flow (M) -27.06

Stock Valuations

P/E -2.22
P/E Growth Ratio -0.05
P/BV 1.95
P/CF -8.94

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.